Viz HCM Overview

The Problem

Hypertrophic cardiomyopathy (HCM) is the most common, inherited cardiovascular disease and one of the leading causes of sudden cardiac death in people under age 35. According to the American Heart Association, it is estimated that 1 in every 500 (or more recently, 1 in every 200) people have HCM. However, only 20% of people with this disease are diagnosed and the time to diagnosis takes years.

The Solution

Viz HCM is an AI-powered, mobile-based algorithm designed to advance disease detection and cardiac care coordination. Viz HCM:

  1. Detects suspected HCM from electrocardiograms (ECGs) in real time, and
  2. Directs patients to the appropriate care specialists for further recommended workup.

Ultimately, Viz HCM helps healthcare providers diagnose patients that would otherwise go undetected and reduces the time to diagnosis.

Key Stats

The Product

The De Novo request provides a marketing pathway to classify novel medical devices for which there are no predicate devices. We are the only approved HCM algorithm on the market. 

The Viz HCM algorithm:

  • Analyzes  12-lead ECG
  • Approved for use on patients 18 and up

Viz houses the ECG and ECHO data in one platform for easy access and sharing in a HIPPA-compliant app. 

Increase productivity with Viz HCM's integrated capabilities

In addition to ECG AI, ECG high-fidelity viewer, and HIPAA-compliant communications, Viz HCM includes echocardiogram, EMR integrations with leading companies such as Epic and Cerner,

and cardiac MRI, bringing all essential information into one comprehensive view to increase

speed to diagnosis and treatment.

Comprehensive Patient View with EMR-Enhanced Viz HCM

  • Gain clinical context alongside imaging results
  • Quickly rule in or rule out disease mimics or those with existing HCM diagnosis
  • Automate manual pre-screening process with smart filters

Echo Abnormal Alerts and Reporting, Anywhere, Anytime

  • Inform decisions with real-time access to echos and echo reports on your phone or computer
  • Accelerate efficient team decision making by easily sharing echos and echo reports with your care team
  • Receive notifications when an echo for a patient with suspected HCM has been completed or when there are user selected threshold notifications on echos (via Viz HCM’s Us2.ai integration)

Learn more about Viz HCM at viz.ai/hypertrophic-cardiomyopathy

Did this answer your question? Thanks for the feedback There was a problem submitting your feedback. Please try again later.